Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF) — Professor Gregory Lip (2018) | RDL Network
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)
Andreas Goette, Joris R. de Groot, Jean‐Yves Le Heuzey, Maciej Banach, Kurt Huber, James Jin, Michael Melino, Shannon M. Winters, Sakis Themistoclakis, Professor Gregory Lip
Andreas Goette, José Luís Merino, Michael D. Ezekowitz, Dmitry Zamoryakhin, Michael Melino, James Jin, Michele Mercuri, Michael Grosso, Víctor Fernández, Naab Al‐Saady, Natalya Pelekh, Béla Merkely, Sergey Zenin, Mykola Kushnir, Jindřich Špinar, Valeriy Batushkin, Joris R. de Groot, Professor Gregory Lip
Andreas Goette, José Luís Merino, Raffaele De Caterina, Kurt Huber, Hein Heidbüchel, James Jin, Michael Melino, Shannon M. Winters, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.